Who gets the weight loss drugs when supply doesn’t meet demand?

Reuters World News - A podcast by Reuters

A revolutionary new class of drugs is transforming weight loss. But around the world, demand is skyrocketing for diabetes drugs because they also help people shed pounds. Join our global health journalists as we explore access to drugs like Wegovy and Ozempic and the transformation of the way we understand weight loss. Learn more about your ad choices. Visit megaphone.fm/adchoices